Technicians don't like to read the papers, so Greg Harmon is looking at the action in big cap...
Technicians don't like to read the papers, so Greg Harmon is looking at the action in big cap pharma stocks and it's telling him they're going to like the outcome of the Supreme Court ruling on Obamacare. Bristol-Myers (BMY), Eli Lilly (LLY), Merck (MRK), and Pfizer (PFE) - all yielding nearly 4% or more - are all on the verge of long-term breakouts.
From other sites
Video at CNBC.com (Sep 9, 2015)
Video at CNBC.com (Aug 21, 2015)
at CNBC.com (Jun 1, 2015)
Video at CNBC.com (May 26, 2015)
Video at CNBC.com (Mar 5, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs